img

Global Infectious Immunology Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Infectious Immunology Market Research Report 2024

Infection involves an attack of disease-causing agents such as bacteria and viruses on the host organism’s body that causes disturbances in normal functioning. Immunology is the study of the human body’s resistance to these infections. The combined study of infections and immunology would help authorities to handle infectious disease conditions including HIV, hepatitis, pneumonia, tuberculosis, malaria, inflammatory bowel diseases and autoimmune diseases. The infectious immunology market comprises of the diagnosis and treatment of these infectious diseases with the help of antigen antibody reactions.
According to MRAResearch’s new survey, global Infectious Immunology market is projected to reach US$ 37790 million in 2033, increasing from US$ 22160 million in 2022, with the CAGR of 7.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Infectious Immunology market research.
The global immunology market is gaining momentum due to the availability of various drugs approved by regulatory authorities and trends of improving clinical efficacy for new drug approvals. The high prevalence of immunological disorders further drives the market. The growing number of successful clinical trials due to environmental factors and the demand for biologics leads companies to invest in developing an affordable and effective imitation of biologic drugs and biosimilars. Furthermore, the ever-increasing cases of immunological diseases worldwide due to increasing geriatric populations and the adoption of sedentary lifestyles are pushing the market for growth. Additionally, the rising research and development activities in life sciences and biologics, including immunological drugs, will support market growth. Furthermore, the growing support from the governmental bodies and the approvals from the FDA for clinical trials are expected to enhance the market revenue from the governmental bodies and the approvals from the FDA for clinical trials are expected to enhance the market revenue.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Infectious Immunology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abbott Laboratories
Roche Diagnostics
Thermo Fisher Scientifics
Bio-Rad Laboratories
Dr. Reddy’s Laboratories
AbbVie Inc
Janssen Global Services
Johnson & Johnson
Amgen Inc
Pfizer Inc
Novartis
Astellas
Bristol-Myers Squibb Company
Merck Sharp & Dohme Corp
UCB SA
Allergan
Segment by Type
Diagnostic Kits
Instruments
Reagents

Segment by Application


HIV
TB
HBV and HCV
Pneumonia
Malaria
Inflammatory Bowel Diseases
Auto Immune Diseases
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Infectious Immunology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Immunology Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Diagnostic Kits
1.2.3 Instruments
1.2.4 Reagents
1.3 Market by Application
1.3.1 Global Infectious Immunology Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 HIV
1.3.3 TB
1.3.4 HBV and HCV
1.3.5 Pneumonia
1.3.6 Malaria
1.3.7 Inflammatory Bowel Diseases
1.3.8 Auto Immune Diseases
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Immunology Market Perspective (2018-2033)
2.2 Infectious Immunology Growth Trends by Region
2.2.1 Global Infectious Immunology Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Infectious Immunology Historic Market Size by Region (2018-2023)
2.2.3 Infectious Immunology Forecasted Market Size by Region (2024-2033)
2.3 Infectious Immunology Market Dynamics
2.3.1 Infectious Immunology Industry Trends
2.3.2 Infectious Immunology Market Drivers
2.3.3 Infectious Immunology Market Challenges
2.3.4 Infectious Immunology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Immunology Players by Revenue
3.1.1 Global Top Infectious Immunology Players by Revenue (2018-2023)
3.1.2 Global Infectious Immunology Revenue Market Share by Players (2018-2023)
3.2 Global Infectious Immunology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Immunology Revenue
3.4 Global Infectious Immunology Market Concentration Ratio
3.4.1 Global Infectious Immunology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Immunology Revenue in 2022
3.5 Infectious Immunology Key Players Head office and Area Served
3.6 Key Players Infectious Immunology Product Solution and Service
3.7 Date of Enter into Infectious Immunology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Immunology Breakdown Data by Type
4.1 Global Infectious Immunology Historic Market Size by Type (2018-2023)
4.2 Global Infectious Immunology Forecasted Market Size by Type (2024-2033)
5 Infectious Immunology Breakdown Data by Application
5.1 Global Infectious Immunology Historic Market Size by Application (2018-2023)
5.2 Global Infectious Immunology Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Infectious Immunology Market Size (2018-2033)
6.2 North America Infectious Immunology Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Infectious Immunology Market Size by Country (2018-2023)
6.4 North America Infectious Immunology Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Immunology Market Size (2018-2033)
7.2 Europe Infectious Immunology Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Infectious Immunology Market Size by Country (2018-2023)
7.4 Europe Infectious Immunology Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Immunology Market Size (2018-2033)
8.2 Asia-Pacific Infectious Immunology Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Infectious Immunology Market Size by Region (2018-2023)
8.4 Asia-Pacific Infectious Immunology Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Immunology Market Size (2018-2033)
9.2 Latin America Infectious Immunology Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Infectious Immunology Market Size by Country (2018-2023)
9.4 Latin America Infectious Immunology Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Immunology Market Size (2018-2033)
10.2 Middle East & Africa Infectious Immunology Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Infectious Immunology Market Size by Country (2018-2023)
10.4 Middle East & Africa Infectious Immunology Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Infectious Immunology Introduction
11.1.4 Abbott Laboratories Revenue in Infectious Immunology Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Detail
11.2.2 Roche Diagnostics Business Overview
11.2.3 Roche Diagnostics Infectious Immunology Introduction
11.2.4 Roche Diagnostics Revenue in Infectious Immunology Business (2018-2023)
11.2.5 Roche Diagnostics Recent Development
11.3 Thermo Fisher Scientifics
11.3.1 Thermo Fisher Scientifics Company Detail
11.3.2 Thermo Fisher Scientifics Business Overview
11.3.3 Thermo Fisher Scientifics Infectious Immunology Introduction
11.3.4 Thermo Fisher Scientifics Revenue in Infectious Immunology Business (2018-2023)
11.3.5 Thermo Fisher Scientifics Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Detail
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Infectious Immunology Introduction
11.4.4 Bio-Rad Laboratories Revenue in Infectious Immunology Business (2018-2023)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Dr. Reddy’s Laboratories
11.5.1 Dr. Reddy’s Laboratories Company Detail
11.5.2 Dr. Reddy’s Laboratories Business Overview
11.5.3 Dr. Reddy’s Laboratories Infectious Immunology Introduction
11.5.4 Dr. Reddy’s Laboratories Revenue in Infectious Immunology Business (2018-2023)
11.5.5 Dr. Reddy’s Laboratories Recent Development
11.6 AbbVie Inc
11.6.1 AbbVie Inc Company Detail
11.6.2 AbbVie Inc Business Overview
11.6.3 AbbVie Inc Infectious Immunology Introduction
11.6.4 AbbVie Inc Revenue in Infectious Immunology Business (2018-2023)
11.6.5 AbbVie Inc Recent Development
11.7 Janssen Global Services
11.7.1 Janssen Global Services Company Detail
11.7.2 Janssen Global Services Business Overview
11.7.3 Janssen Global Services Infectious Immunology Introduction
11.7.4 Janssen Global Services Revenue in Infectious Immunology Business (2018-2023)
11.7.5 Janssen Global Services Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Detail
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Infectious Immunology Introduction
11.8.4 Johnson & Johnson Revenue in Infectious Immunology Business (2018-2023)
11.8.5 Johnson & Johnson Recent Development
11.9 Amgen Inc
11.9.1 Amgen Inc Company Detail
11.9.2 Amgen Inc Business Overview
11.9.3 Amgen Inc Infectious Immunology Introduction
11.9.4 Amgen Inc Revenue in Infectious Immunology Business (2018-2023)
11.9.5 Amgen Inc Recent Development
11.10 Pfizer Inc
11.10.1 Pfizer Inc Company Detail
11.10.2 Pfizer Inc Business Overview
11.10.3 Pfizer Inc Infectious Immunology Introduction
11.10.4 Pfizer Inc Revenue in Infectious Immunology Business (2018-2023)
11.10.5 Pfizer Inc Recent Development
11.11 Novartis
11.11.1 Novartis Company Detail
11.11.2 Novartis Business Overview
11.11.3 Novartis Infectious Immunology Introduction
11.11.4 Novartis Revenue in Infectious Immunology Business (2018-2023)
11.11.5 Novartis Recent Development
11.12 Astellas
11.12.1 Astellas Company Detail
11.12.2 Astellas Business Overview
11.12.3 Astellas Infectious Immunology Introduction
11.12.4 Astellas Revenue in Infectious Immunology Business (2018-2023)
11.12.5 Astellas Recent Development
11.13 Bristol-Myers Squibb Company
11.13.1 Bristol-Myers Squibb Company Company Detail
11.13.2 Bristol-Myers Squibb Company Business Overview
11.13.3 Bristol-Myers Squibb Company Infectious Immunology Introduction
11.13.4 Bristol-Myers Squibb Company Revenue in Infectious Immunology Business (2018-2023)
11.13.5 Bristol-Myers Squibb Company Recent Development
11.14 Merck Sharp & Dohme Corp
11.14.1 Merck Sharp & Dohme Corp Company Detail
11.14.2 Merck Sharp & Dohme Corp Business Overview
11.14.3 Merck Sharp & Dohme Corp Infectious Immunology Introduction
11.14.4 Merck Sharp & Dohme Corp Revenue in Infectious Immunology Business (2018-2023)
11.14.5 Merck Sharp & Dohme Corp Recent Development
11.15 UCB SA
11.15.1 UCB SA Company Detail
11.15.2 UCB SA Business Overview
11.15.3 UCB SA Infectious Immunology Introduction
11.15.4 UCB SA Revenue in Infectious Immunology Business (2018-2023)
11.15.5 UCB SA Recent Development
11.16 Allergan
11.16.1 Allergan Company Detail
11.16.2 Allergan Business Overview
11.16.3 Allergan Infectious Immunology Introduction
11.16.4 Allergan Revenue in Infectious Immunology Business (2018-2023)
11.16.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Infectious Immunology Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Diagnostic Kits
Table 3. Key Players of Instruments
Table 4. Key Players of Reagents
Table 5. Global Infectious Immunology Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Infectious Immunology Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Infectious Immunology Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Infectious Immunology Market Share by Region (2018-2023)
Table 9. Global Infectious Immunology Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Infectious Immunology Market Share by Region (2024-2033)
Table 11. Infectious Immunology Market Trends
Table 12. Infectious Immunology Market Drivers
Table 13. Infectious Immunology Market Challenges
Table 14. Infectious Immunology Market Restraints
Table 15. Global Infectious Immunology Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Infectious Immunology Market Share by Players (2018-2023)
Table 17. Global Top Infectious Immunology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Immunology as of 2022)
Table 18. Ranking of Global Top Infectious Immunology Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Infectious Immunology Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Infectious Immunology Product Solution and Service
Table 22. Date of Enter into Infectious Immunology Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Infectious Immunology Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Infectious Immunology Revenue Market Share by Type (2018-2023)
Table 26. Global Infectious Immunology Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Infectious Immunology Revenue Market Share by Type (2024-2033)
Table 28. Global Infectious Immunology Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Infectious Immunology Revenue Market Share by Application (2018-2023)
Table 30. Global Infectious Immunology Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Infectious Immunology Revenue Market Share by Application (2024-2033)
Table 32. North America Infectious Immunology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Infectious Immunology Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Infectious Immunology Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Infectious Immunology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Infectious Immunology Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Infectious Immunology Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Infectious Immunology Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Infectious Immunology Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Infectious Immunology Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Infectious Immunology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Infectious Immunology Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Infectious Immunology Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Infectious Immunology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Infectious Immunology Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Infectious Immunology Market Size by Country (2024-2033) & (US$ Million)
Table 47. Abbott Laboratories Company Detail
Table 48. Abbott Laboratories Business Overview
Table 49. Abbott Laboratories Infectious Immunology Product
Table 50. Abbott Laboratories Revenue in Infectious Immunology Business (2018-2023) & (US$ Million)
Table 51. Abbott Laboratories Recent Development
Table 52. Roche Diagnostics Company Detail
Table 53. Roche Diagnostics Business Overview
Table 54. Roche Diagnostics Infectious Immunology Product
Table 55. Roche Diagnostics Revenue in Infectious Immunology Business (2018-2023) & (US$ Million)
Table 56. Roche Diagnostics Recent Development
Table 57. Thermo Fisher Scientifics Company Detail
Table 58. Thermo Fisher Scientifics Business Overview
Table 59. Thermo Fisher Scientifics Infectious Immunology Product
Table 60. Thermo Fisher Scientifics Revenue in Infectious Immunology Business (2018-2023) & (US$ Million)
Table 61. Thermo Fisher Scientifics Recent Development
Table 62. Bio-Rad Laboratories Company Detail
Table 63. Bio-Rad Laboratories Business Overview
Table 64. Bio-Rad Laboratories Infectious Immunology Product
Table 65. Bio-Rad Laboratories Revenue in Infectious Immunology Business (2018-2023) & (US$ Million)
Table 66. Bio-Rad Laboratories Recent Development
Table 67. Dr. Reddy’s Laboratories Company Detail
Table 68. Dr. Reddy’s Laboratories Business Overview
Table 69. Dr. Reddy’s Laboratories Infectious Immunology Product
Table 70. Dr. Reddy’s Laboratories Revenue in Infectious Immunology Business (2018-2023) & (US$ Million)
Table 71. Dr. Reddy’s Laboratories Recent Development
Table 72. AbbVie Inc Company Detail
Table 73. AbbVie Inc Business Overview
Table 74. AbbVie Inc Infectious Immunology Product
Table 75. AbbVie Inc Revenue in Infectious Immunology Business (2018-2023) & (US$ Million)
Table 76. AbbVie Inc Recent Development
Table 77. Janssen Global Services Company Detail
Table 78. Janssen Global Services Business Overview
Table 79. Janssen Global Services Infectious Immunology Product
Table 80. Janssen Global Services Revenue in Infectious Immunology Business (2018-2023) & (US$ Million)
Table 81. Janssen Global Services Recent Development
Table 82. Johnson & Johnson Company Detail
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Infectious Immunology Product
Table 85. Johnson & Johnson Revenue in Infectious Immunology Business (2018-2023) & (US$ Million)
Table 86. Johnson & Johnson Recent Development
Table 87. Amgen Inc Company Detail
Table 88. Amgen Inc Business Overview
Table 89. Amgen Inc Infectious Immunology Product
Table 90. Amgen Inc Revenue in Infectious Immunology Business (2018-2023) & (US$ Million)
Table 91. Amgen Inc Recent Development
Table 92. Pfizer Inc Company Detail
Table 93. Pfizer Inc Business Overview
Table 94. Pfizer Inc Infectious Immunology Product
Table 95. Pfizer Inc Revenue in Infectious Immunology Business (2018-2023) & (US$ Million)
Table 96. Pfizer Inc Recent Development
Table 97. Novartis Company Detail
Table 98. Novartis Business Overview
Table 99. Novartis Infectious Immunology Product
Table 100. Novartis Revenue in Infectious Immunology Business (2018-2023) & (US$ Million)
Table 101. Novartis Recent Development
Table 102. Astellas Company Detail
Table 103. Astellas Business Overview
Table 104. Astellas Infectious Immunology Product
Table 105. Astellas Revenue in Infectious Immunology Business (2018-2023) & (US$ Million)
Table 106. Astellas Recent Development
Table 107. Bristol-Myers Squibb Company Company Detail
Table 108. Bristol-Myers Squibb Company Business Overview
Table 109. Bristol-Myers Squibb Company Infectious Immunology Product
Table 110. Bristol-Myers Squibb Company Revenue in Infectious Immunology Business (2018-2023) & (US$ Million)
Table 111. Bristol-Myers Squibb Company Recent Development
Table 112. Merck Sharp & Dohme Corp Company Detail
Table 113. Merck Sharp & Dohme Corp Business Overview
Table 114. Merck Sharp & Dohme Corp Infectious Immunology Product
Table 115. Merck Sharp & Dohme Corp Revenue in Infectious Immunology Business (2018-2023) & (US$ Million)
Table 116. Merck Sharp & Dohme Corp Recent Development
Table 117. UCB SA Company Detail
Table 118. UCB SA Business Overview
Table 119. UCB SA Infectious Immunology Product
Table 120. UCB SA Revenue in Infectious Immunology Business (2018-2023) & (US$ Million)
Table 121. UCB SA Recent Development
Table 122. Allergan Company Detail
Table 123. Allergan Business Overview
Table 124. Allergan Infectious Immunology Product
Table 125. Allergan Revenue in Infectious Immunology Business (2018-2023) & (US$ Million)
Table 126. Allergan Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Immunology Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Infectious Immunology Market Share by Type: 2022 VS 2033
Figure 3. Diagnostic Kits Features
Figure 4. Instruments Features
Figure 5. Reagents Features
Figure 6. Global Infectious Immunology Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Infectious Immunology Market Share by Application: 2022 VS 2033
Figure 8. HIV Case Studies
Figure 9. TB Case Studies
Figure 10. HBV and HCV Case Studies
Figure 11. Pneumonia Case Studies
Figure 12. Malaria Case Studies
Figure 13. Inflammatory Bowel Diseases Case Studies
Figure 14. Auto Immune Diseases Case Studies
Figure 15. Others Case Studies
Figure 16. Infectious Immunology Report Years Considered
Figure 17. Global Infectious Immunology Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 18. Global Infectious Immunology Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 19. Global Infectious Immunology Market Share by Region: 2022 VS 2033
Figure 20. Global Infectious Immunology Market Share by Players in 2022
Figure 21. Global Top Infectious Immunology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Immunology as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Infectious Immunology Revenue in 2022
Figure 23. North America Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. North America Infectious Immunology Market Share by Country (2018-2033)
Figure 25. United States Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Infectious Immunology Market Share by Country (2018-2033)
Figure 29. Germany Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Asia-Pacific Infectious Immunology Market Share by Region (2018-2033)
Figure 37. China Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Japan Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. South Korea Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Southeast Asia Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. India Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Australia Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Latin America Infectious Immunology Market Share by Country (2018-2033)
Figure 45. Mexico Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Brazil Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East & Africa Infectious Immunology Market Share by Country (2018-2033)
Figure 49. Turkey Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Saudi Arabia Infectious Immunology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Abbott Laboratories Revenue Growth Rate in Infectious Immunology Business (2018-2023)
Figure 52. Roche Diagnostics Revenue Growth Rate in Infectious Immunology Business (2018-2023)
Figure 53. Thermo Fisher Scientifics Revenue Growth Rate in Infectious Immunology Business (2018-2023)
Figure 54. Bio-Rad Laboratories Revenue Growth Rate in Infectious Immunology Business (2018-2023)
Figure 55. Dr. Reddy’s Laboratories Revenue Growth Rate in Infectious Immunology Business (2018-2023)
Figure 56. AbbVie Inc Revenue Growth Rate in Infectious Immunology Business (2018-2023)
Figure 57. Janssen Global Services Revenue Growth Rate in Infectious Immunology Business (2018-2023)
Figure 58. Johnson & Johnson Revenue Growth Rate in Infectious Immunology Business (2018-2023)
Figure 59. Amgen Inc Revenue Growth Rate in Infectious Immunology Business (2018-2023)
Figure 60. Pfizer Inc Revenue Growth Rate in Infectious Immunology Business (2018-2023)
Figure 61. Novartis Revenue Growth Rate in Infectious Immunology Business (2018-2023)
Figure 62. Astellas Revenue Growth Rate in Infectious Immunology Business (2018-2023)
Figure 63. Bristol-Myers Squibb Company Revenue Growth Rate in Infectious Immunology Business (2018-2023)
Figure 64. Merck Sharp & Dohme Corp Revenue Growth Rate in Infectious Immunology Business (2018-2023)
Figure 65. UCB SA Revenue Growth Rate in Infectious Immunology Business (2018-2023)
Figure 66. Allergan Revenue Growth Rate in Infectious Immunology Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed